Thomas Michaeli
17PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Dec 31, 2024
Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated Price and Cost Savings for Cancer Drugs.Daniel Tobias Michaeli, Thomas Michaeli
|Sep 25, 2024
Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price.Julia Caroline Michaeli, Thomas Michaeli, Dario Trapani
|Jul 31, 2024
Patient Enrollment per Month (Accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs.Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers
|May 17, 2024
Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications.Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers
|Nov 14, 2023
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy.Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers
|Oct 19, 2023
Launch and Post-Launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition.Daniel Tobias Michaeli, Thomas Michaeli
Pageof 3
Frequent Collaborators
17 joint publications
Daniel Tobias Michaeli
10 joint publications
Julia Caroline Michaeli
7 joint publications
Sebastian Albers
5 joint publications
Tobias Boch
1 joint publications
Mackenzie Mills
1 joint publications
Aurelio Miracolo
1 joint publications
Panos Kanavos
1 joint publications
Hendrik Jürges
1 joint publications
Dario Trapani
1 joint publications
Dominik Dannehl
